PF-06954522

DRUG2 trials

Sponsors

Pfizer

Conditions

Healthy ParticipantsObesityType 2 Diabetes Mellitus (T2DM)

Phase 1

A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults

CompletedNCT06003777

PfizerHealthy Participants

Start: 2023-08-30End: 2024-02-20Updated: 2025-06-24

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

CompletedNCT06279234

PfizerObesity, Type 2 Diabetes Mellitus (T2DM)

Start: 2024-02-20End: 2025-04-11Updated: 2025-06-03